Kimberly K. Leslie - Concepedia

Author

Kimberly K. Leslie

Also Known As

A Alqahtani, A Dubrowski, K K Leslie, K LESLIE, K Leslie, K. K. Leslie, K. Leslie, K.K. Leslie, KAREN LESLIE, KIMBERLY K. LESLIE

335

Publications

7.3K

Citations

H-Index

139

Concepts

All Affiliations

University of Iowa University of New Mexico University of Colorado Health University of Iowa Hospitals and Clinics Roswell Park Comprehensive Cancer Center

About

Kimberly K. Leslie is an author at University of Iowa specializing in medicine, obstetrics, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	76	4.4K
2	Public Health	11	11	463
3	Health Sciences	5	5	893
4	Engineering	2	2	96
5	Natural Sciences	2	2	73

Kimberly K. Leslie

116

Publications

Citations

H-Index

Page 1

	Year	Citations
The effect of elective total hip replacement on health-related quality of life. Andreas Laupacis, Robert B. Bourne, C H Rorabeck, Journal of Bone and Joint Surgery Quality Of LifeFemoral Head ProsthesesHealth OutcomeHealth-related QualityNon-operative Management	1993	611
Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study Carol Aghajanian, Michael W. Sill, Kathleen M. Darcy, Journal of Clinical Oncology	2011	312
GPR30: a novel indicator of poor survival for endometrial carcinoma Harriet O. Smith, Kimberly K. Leslie, Meenakshi Singh, American Journal of Obstetrics and Gynecology MedicineCancer ManagementGynecologyOncologyRadiation Oncology	2007	212
Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: A Gynecologic Oncology Group Study Meenakshi Singh, Richard J. Zaino, Virginia L. Filiaci, Gynecologic Oncology Clinical OutcomeProgesterone ReceptorsHormonal ReceptorGynecologyMetastatic Endometrial Carcinoma	2007	161
Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Donghai Dai, Douglas M. Wolf, Elizabeth S. Litman, PubMed Cellular Adhesion MoleculesAdhesion Molecule ExpressionProgesterone ReceptorsMedicineHormonal Receptor	2002	160
Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action. Nitish Kumar, Julie Richer, Gareth I. Owen, PubMed Hprb RatiosPr IsoformsHprb ExpressionSelective Down-regulationHormonal Receptor	1998	133
Vasopressin in Preeclampsia Mark K. Santillan, Donna A. Santillan, Sabrina M Scroggins, Hypertension HypertensionAvp SecretionPregnancy DisordersGynecologyHigh-risk Pregnancy	2014	126
T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance. Mark L. Graham, Nancy Krett, Louise A. Miller, PubMed Breast OncologyT47dco CellsHormone ResistanceBreast CancersCancer Biology	1990	123
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study Agustin A. García, Michael W. Sill, Heather A. Lankes, Gynecologic Oncology Primary Peritoneal CarcinomaPhase Ii EvaluationMedicineRecurrent Epithelial OvarianCancer Management	2011	121
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study Gini F. Fleming, Virginia L. Filiaci, Brandon Marzullo, Gynecologic Oncology Megestrol AcetateMedicineGynecologyEndometrial CancerOncology	2014	119

Page 1